文献速递前列腺癌

局限性前列腺癌外照射放疗联合低剂量率近距离放疗加强与根治性前列腺切除术后的患者报告结局:前瞻性比较有效性研究的五年结果

Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study.
PubMed 文献 · J Urol · 2022-08-25

本研究前瞻性纳入2011至2012年确诊的局限性前列腺腺癌男性(年龄<80岁),比较外照射放疗联合低剂量率近距离放疗加强(112例)与根治性前列腺切除术(1553例)后5年的患者报告结局。与根治性前列腺切除术相比,联合放疗组排尿刺激/梗阻症状更差、尿失禁功能更好、肠道功能更差,性功能在1年时更好但3年及5年无足够证据排除无差异。

要点

  • 联合放疗组5年排尿刺激/梗阻症状较根治性前列腺切除术组更差,校正后平均评分差异为5.0(95%CI -8.7至-1.3;P=.008)。
  • 联合放疗组5年尿失禁功能较根治性前列腺切除术组更好,校正后平均评分差异为13.3(95%CI 7.7至18.9;P<.001)。
  • 联合放疗组5年肠道功能较根治性前列腺切除术组更差,校正后平均评分差异为-4.0(95%CI -6.9至-1.1;P=.006)。

核心结论

  • 与根治性前列腺切除术相比,外照射放疗联合低剂量率近距离放疗加强在治疗后5年内与临床上有意义的更差排尿刺激/梗阻功能和肠道功能相关,但尿失禁功能更好。
  • 这些患者报告的功能结局可能有助于阐明治疗预期并帮助局限性前列腺癌的治疗选择。

研究设计与样本

  • 前瞻性比较有效性研究,2011至2012年纳入年龄<80岁的局限性前列腺腺癌男性并纵向随访。
  • 研究人群包括112例接受外照射放疗联合低剂量率近距离放疗加强者与1553例接受根治性前列腺切除术者。
  • 患者报告结局采用扩展前列腺指数综合量表(Expanded Prostate Index Composite)评估,构建了校正基线评分与协变量的回归模型。

主要发现

  • 与根治性前列腺切除术相比,外照射放疗联合低剂量率近距离放疗加强在5年时与更差的排尿刺激/梗阻症状相关(校正后平均评分差异[95%CI]:5.0[-8.7,-1.3];P=.008)。
  • 与根治性前列腺切除术相比,外照射放疗联合低剂量率近距离放疗加强在5年时与更好的尿失禁功能相关(校正后平均评分差异[95%CI]:13.3[7.7,18.9];P<.001)。
  • 两组排尿功能困扰在所有时间点均相似(P>.4)。
  • 与根治性前列腺切除术相比,外照射放疗联合低剂量率近距离放疗加强在5年时与更差的肠道功能相关(校正后平均评分差异[95%CI]:-4.0[-6.9,-1.1];P=.006)。
  • 与根治性前列腺切除术相比,外照射放疗联合低剂量率近距离放疗加强在1年时与更好的性功能相关(校正后平均评分差异[95%CI]:12.0[6.5,17.5];P<.001),但3年或5年时无足够证据排除无差异的假设。

关键数值与推荐

  • 排尿刺激/梗阻症状5年校正后平均评分差异为5.0(95%CI -8.7至-1.3;P=.008),联合放疗组更差。
  • 尿失禁功能5年校正后平均评分差异为13.3(95%CI 7.7至18.9;P<.001),联合放疗组更好。
  • 肠道功能5年校正后平均评分差异为-4.0(95%CI -6.9至-1.1;P=.006),联合放疗组更差。
  • 性功能1年校正后平均评分差异为12.0(95%CI 6.5至17.5;P<.001),联合放疗组更好;3年或5年无足够证据排除无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Data comparing radical prostatectomy and external beam radiation therapy with low dose rate brachytherapy boost are lacking. To better guide shared decision making regarding treatment, we compared patient reported outcomes through 5 years following radical prostatectomy or external beam radiation therapy with low dose rate brachytherapy boost for localized prostate cancer. MATERIALS AND METHODS: From 2011-2012, men aged <80 years with localized prostate adenocarcinoma were enrolled and followed longitudinally. Patient reported outcomes included the Expanded Prostate Index Composite. Regression models adjusted for baseline scores and covariates were constructed. RESULTS: The study population included 112 men treated with external beam radiation therapy with low dose rate brachytherapy boost and 1,553 treated with radical prostatectomy. Compared to radical prostatectomy, external beam radiation therapy with low dose rate brachytherapy boost was associated with clinically meaningful worse urinary irritative/obstructive (adjusted mean score difference [95% confidence interval]: 5.0 [-8.7, -1.3]; P = .008 at 5 years) and better urinary incontinence function (13.3 [7.7, 18.9]; P < .001 at 5 years) through 5 years. Urinary function bother was similar between groups (P > .4 at all timepoints). Treatment with external beam radiation therapy with low dose rate brachytherapy boost was associated with worse bowel function (-4.0 [-6.9, -1.1]; P = .006 at 5 years) through 5 years compared to radical prostatectomy. Treatment with external beam radiation therapy with low dose rate brachytherapy boost was associated with better sexual function at 1 year (12.0 [6.5, 17.5]; P < .001 at 1 year) compared to radical prostatectomy, but there was insufficient evidence to reject the supposition that no difference was seen at 3 or 5 years. CONCLUSIONS: Compared to radical prostatectomy, external beam radiation therapy with low dose rate brachytherapy boost was associated with clinically meaningful worse urinary irritative/obstructive and bowel functions but better urinary incontinence function through 5 years after treatment. These patient-reported functional outcomes may clarify treatment expectations and help inform treatment choices for localized prostate cancer.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. De B, Pasalic D, Barocas DA, et al. Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study. J Urol. 2022. PMID: 36006050. doi:10.1097/JU.0000000000002902

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。